5CV — CureVac NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for CureVac NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,323	813	498	404	485
Net Total Accounts Receivable
Net Total Receivables	4.01	21.2	11.6	23	22.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,390	940	584	478	526
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	101	200	242	279	245
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,511	1,158	860	788	803
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	248	358	156	186	72.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	800	470	327	271	106
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	711	688	533	517	697
Total Liabilities & Shareholders' Equity	1,511	1,158	860	788	803
Total Common Shares Outstanding